Mahai Chris LaVictoire
Transaction: 06/09/2026
OTHER
Change
0
Price
Not reported
Filing
06/11/2026
Type
OTHER
Tekla Life Sciences Investors
HQL • Asset Management
$20.64
— 0.00 (0.00%)
EarningsLatest report: Sep 30, 2025
FAVORABLE PROFILEAttractiveConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$595.93M
Growth
-10.0%
Cash Flow
0/5
Trend
Negative
Evidence
Stable or improving margins · 99.1%Positive revenue growth · 12.7%Reasonable earnings multiple · 5.23Manageable debt level · 0Healthy liquidity · 1.74
Financial data as of: Sep 30, 2025, 12:00 AM UTCLast earnings update: Sep 30, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$20.64
Change0.00%
Shares Out28.87M
Market Cap$595.93M
Enterprise Value$595.85M
52W Range12.34 - 18.46
Beta0.74
P/E3.49
P/S17.62
P/B1.16
P/FCF-256.83
EV/Sales17.62
Price$20.64
Change0.00%
Shares Out28.87M
Market Cap$595.93M
Enterprise Value$595.85M
52W Range12.34 - 18.46
Beta0.74
P/E3.49
P/S17.62
P/B1.16
P/FCF-256.83
EV/Sales17.62
EV/EBITDA3.19
EV/FCF-256.80
Earnings Yield28.68%
FCF Yield-0.39%
Dividend Yield18.05%
Gross Margin100.00%
Oper. Margin99.08%
Profit Margin99.08%
Debt/Eq0.00
Current Ratio1.74
Quick Ratio1.74
Revenue 5Y-9.97%
Volume136.95K
Avg Volume103.51K
Investment DNA
How strong this company looks for long-term investors
72
out of 100
Business Quality
Margins, moat, returns
85/100
Financial Strength
Debt, cash, stability
67/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
86/100
Why this score▼
Stable or improving margins · 99.1%Positive revenue growth · 12.7%Reasonable earnings multiple · 5.23Manageable debt level · 0Healthy liquidity · 1.74
Analyst view
No analyst data available now.
Insider Transactions
Recent executive and insider activity
Reilly Heather Carter
Transaction: 12/09/2025
OTHER
Change
0
Price
Not reported
Filing
12/19/2025
Type
OTHER
Pittard Christian
Transaction: 12/16/2025
BUY
Change
+7,923
Price
$16.88
Filing
12/18/2025
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Mahai Chris LaVictoire | OTHER | 0 | Not reported | 06/09/2026 | 06/11/2026 |
| Reilly Heather Carter | OTHER | 0 | Not reported | 12/09/2025 | 12/19/2025 |
| Pittard Christian | BUY | +7,923 | $16.88 | 12/16/2025 | 12/18/2025 |
| Saba Capital Management, L.P. | SELL | -41,623 | $14.14 | 09/22/2025 | 09/23/2025 |
| Saba Capital Management, L.P. | SELL | -6,989 | $14.10 | 09/19/2025 | 09/23/2025 |
| Saba Capital Management, L.P. | SELL | -40,208 | $14.07 | 09/18/2025 | 09/19/2025 |
| Saba Capital Management, L.P. | SELL | -24,328 | $13.99 | 09/17/2025 | 09/19/2025 |
| Saba Capital Management, L.P. | SELL | -2,026 | $13.99 | 09/16/2025 | 09/17/2025 |
| Saba Capital Management, L.P. | SELL | -700 | $14.13 | 09/15/2025 | 09/17/2025 |
| Saba Capital Management, L.P. | SELL | -15,116 | $14.28 | 09/11/2025 | 09/15/2025 |
| Saba Capital Management, L.P. | SELL | -14,083 | $14.04 | 09/02/2025 | 09/04/2025 |
| Saba Capital Management, L.P. | SELL | -23,723 | $13.89 | 08/29/2025 | 09/02/2025 |
| Saba Capital Management, L.P. | SELL | -400 | $13.83 | 08/26/2025 | 08/27/2025 |
| Saba Capital Management, L.P. | SELL | -10,710 | $14.07 | 08/21/2025 | 08/25/2025 |
| Dietrick Joseph Francis | OTHER | 0 | Not reported | 07/17/2025 | 07/22/2025 |
| Saba Capital Management, L.P. | SELL | -11,419 | $12.71 | 05/20/2025 | 05/22/2025 |
| Saba Capital Management, L.P. | SELL | -23,729 | $12.08 | 05/15/2025 | 05/19/2025 |
| Saba Capital Management, L.P. | SELL | -600 | $12.04 | 05/14/2025 | 05/15/2025 |
| Saba Capital Management, L.P. | SELL | -730 | $12.28 | 05/13/2025 | 05/15/2025 |
| Saba Capital Management, L.P. | SELL | -12,689 | $11.98 | 05/08/2025 | 05/12/2025 |